HR 3520
116th Congress
House
Health
Advisory bodies
Blood and blood diseases
Cell biology and embryology
Health programs administration and funding
Medical research
Organ and tissue donation and transplantation
Research administration and funding
Stem Cell Therapeutic and Research Reauthorization Act of 2019
Introduced: June 26, 2019
Introduced by:
Smith, Christopher H.
Republican
· New Jersey
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 27, 2019
Referred to the Subcommittee on Health.
Jun 26, 2019
Referred to the House Committee on Energy and Commerce.
Jun 26, 2019
Introduced in House
Plain-English summary
Stem Cell Therapeutic and Research Reauthorization Act of 2019
This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.
The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1